Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
EV/Core EBITDA

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

OXYGENTA PHARMACEUTICAL Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) -42.25-15.97-16.8858.1714.65

What is the latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL ?

The latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL is -42.25 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar2025-42.25
Mar2024-15.97
Mar2023-16.88
Mar202258.17
Mar202114.65

How is EV/Core EBITDA of OXYGENTA PHARMACEUTICAL Trending?

Years EV/Core EBITDA % Change
Mar2025 -42.25
Negative
Mar2024 -15.97
Negative
Mar2023 -16.88
Negative
Mar2022 58.17
297.06
Mar2021 14.65 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare EV/Core EBITDA ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹216.5 Cr -3.6% 5% -26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-3.6%

5%

-26.7%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses